The estimated Net Worth of Craig N. Hansen is at least 8.76 百万$ dollars as of 12 March 2012. Craig Hansen owns over 3,750 units of Electromed stock worth over 8,692,110$ and over the last 13 years Craig sold ELMD stock worth over 64,877$.
Craig has made over 4 trades of the Electromed stock since 2011, according to the Form 4 filled with the SEC. Most recently Craig sold 3,750 units of ELMD stock worth 66,150$ on 12 March 2012.
The largest trade Craig's ever made was selling 10,000 units of Electromed stock on 2 June 2011 worth over 30,000$. On average, Craig trades about 4,690 units every 57 days since 2011. As of 12 March 2012 Craig still owns at least 492,750 units of Electromed stock.
You can see the complete history of Craig Hansen stock trades at the bottom of the page.
Craig's mailing address filed with the SEC is C/O ELECTROMED, INC., 500 SIXTH STREET NW, NEW PRAGUE, MN, 56071.
Over the last 14 years, insiders at Electromed have traded over 2,585,226$ worth of Electromed stock and bought 684,801 units worth 2,582,707$ . The most active insiders traders include Oak Partners, Llc Red、Stephen H. Craney、Kathleen Skarvan. On average, Electromed executives and independent directors trade stock every 84 days with the average trade being worth of 358,798$. The most recent stock trade was executed by James L. Cunniff on 1 March 2024, trading 9,000 units of ELMD stock currently worth 137,250$.
electromed, inc. is a minnesota-based company (nyse mkt: elmd) and the innovative leader in the development, manufacture, and worldwide sales of the smartvest® airway clearance system. the patented system uses high frequency chest wall oscillation (hfcwo), a better-tolerated alternative to chest physiotherapy (cpt), to deliver vigorous, yet comfortable airway clearance treatment for patients battling the consequences of retained secretions. hfcwo has been clinically proven to clear the lungs of excess mucus, improve and reduce lung infections for individuals suffering from various conditions including atelectasis, copd, bronchiectasis, neuromuscular diseases, and cystic fibrosis. electromed, inc. is accredited by the joint commission and is iso 13485:2003 and iso 9001:2008 certified.
Electromed executives and other stock owners filed with the SEC include: